The firm’s Corporate Finance team has advised Nodus, founded by Cumulus Oncology and in partnership with the Lead Discovery Center Burges Salmon’s Corporate Finance team has advised biotech company Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets...

Cytomos, an Edinburgh-based life science company, has secured funding to progress its novel cell analysis platform Burges Salmon has advised Cytomos Limited on its £1.6 million funding from a trio of investors to progress the development and qualification of its novel cell analysis platform, Cytomos...